Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0789 | 0.2509 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.2162 | 0.996 | 0.996 |
Schistosoma mansoni | hypothetical protein | 0.0789 | 0.2509 | 0.2509 |
Onchocerca volvulus | 0.2162 | 0.996 | 1 | |
Onchocerca volvulus | 0.0789 | 0.2509 | 0.2519 | |
Mycobacterium ulcerans | hypothetical protein | 0.0327 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2162 | 0.996 | 1 |
Onchocerca volvulus | 0.1835 | 0.8185 | 0.8218 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0789 | 0.2509 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0789 | 0.2509 | 0.2519 |
Brugia malayi | Kringle domain containing protein | 0.0789 | 0.2509 | 0.2519 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0789 | 0.2509 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0789 | 0.2509 | 0.2519 |
Loa Loa (eye worm) | hypothetical protein | 0.0789 | 0.2509 | 0.2519 |
Loa Loa (eye worm) | hypothetical protein | 0.2162 | 0.996 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0331 | 0.002 | 0.002 |
Brugia malayi | Trypsin family protein | 0.2162 | 0.996 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0789 | 0.2509 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0789 | 0.2509 | 0.5 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0789 | 0.2509 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.1633 | 0.7088 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.1633 | 0.7088 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 20 mm | Antibacterial activity against Escherichia coli NCIM 2065 assessed as diameter of growth zone inhibition after 24 hr by disk diffusion method | ChEMBL. | No reference |
MIC (functional) | = 10 ug ml-1 | Antibacterial activity against Escherichia coli NCIM 2065 assessed as growth inhibition after 48 hr by NCCLS broth dilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.